The Associations between Apolipoprotein E Gene Epsilon2/Epsilon3/Epsilon4 Polymorphisms and the Risk of Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus

Frontiers in Physiology
Jian-Quan LuoDa-Xiong Xiang

Abstract

Background and Objective: Apolipoprotein E (APOE) plays important roles in lipoprotein metabolism and cardiovascular disease. Evidence suggests the APOE gene epsilon2/epsilon3/epsilon4 (ε2/ε3/ε4) polymorphisms might be associated with the susceptibility of coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM). However, no clear consensus has yet been established. Therefore, the aim of this meta-analysis is to provide a precise conclusion on the potential association between APOE ε2/ε3/ε4 polymorphisms and the risk of CAD in patients with T2DM based on case-control studies. Methods: Pubmed, Embase, Chinese National Knowledge Infrastructure (CNKI), and Wanfang databases were searched for all relevant studies prior to August 2017 in English and Chinese language. The pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were used to assess the strength of the relationships. The between-study heterogeneity was evaluated by Cochran's Q-test and the I2 index to adopt fixed- or random- effect models. Results: A total of 13 studies were eligible for inclusion. There was evidence for significant associations between APOE ε4 mutation and the risk of CAD in patients with T2DM (for ε3/ε4 vs...Continue Reading

References

Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Aug 31, 2001·Journal of the American College of Cardiology·V MohanUNKNOWN Chennai Urban Population Study (CUPS No.5)
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Jul 21, 2004·Annals of Internal Medicine·Yiqing SongSimin Liu
Aug 18, 2004·Trends in Genetics : TIG·Marcus R Munafò, Jonathan Flint
Nov 17, 2004·Current Pharmaceutical Design·A J JenkinsR L Klein
Sep 20, 2007·JAMA : the Journal of the American Medical Association·Anna M BennetJohn Danesh
Apr 24, 2012·Cardiovascular Diabetology·Rajesh ChaudharyCharn Sriratanasathavorn
May 4, 2013·European Heart Journal·Francesco PaneniFrancesco Cosentino
Nov 19, 2015·Frontiers in Physiology·Leandro C Freitas LimaCamille de Moura Balarini
Nov 22, 2016·BioMed Research International·Min XuLina Wang
Jul 19, 2017·International Heart Journal·Ryo Naito, Katsumi Miyauchi
Jul 21, 2017·PloS One·Laurent LariflaFritz-Line Vélayoudom-Céphise

❮ Previous
Next ❯

Citations

Sep 16, 2019·BMC Cardiovascular Disorders·Sudong LiuZhixiong Zhong
Feb 18, 2021·Genetic Testing and Molecular Biomarkers·Chang GaoGangMing Shu
May 11, 2021·Current Atherosclerosis Reports·A D Marais
Aug 8, 2021·International Journal of Molecular Sciences·Yang WuPing Song

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

MOOSE ( Meta - analysis of
Stata

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.